Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|March 9, 2000
TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy GroupM Mizokami, J K Albrecht, T Kato, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Journal of Viral Hepatitis|November 27, 2010
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialA J Muir, K-Q Hu, S C Gordon, et al.
The New England Journal of Medicine|January 9, 1986
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family settingR M Douglas, B W Moore, H B Miles, et al.
Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Molecular Psychiatry|June 22, 2011
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis CA K Smith, J S Simon, E L Gustafson, et al.
Pageof 3